IPO, focusing on separation and purification equipment and industrial automation control systems.

On May 28th, Ousangyuan Intelligent Equipment Co., Ltd. (referred to as Ousangyuan) has had its IPO application accepted by the Shenzhen Stock Exchange's ChiNext board. Guotai Haitong is the sponsor institution for the company, with plans to raise 1.25105 billion yuan. According to the prospectus, Ousangyuan focuses on purification technology as its core, with process development as its leading factor. The company is mainly engaged in the research, development, production, and sales of purification equipment and industrial automation control systems. During the reporting period, the company's main business income mainly came from purification equipment, industrial automation control systems, and other bio-manufacturing equipment. In terms of process development, the company develops and produces process routes based on specific downstream industry needs and different application scenarios, assisting downstream industries in achieving goals of improving quality, energy saving, reducing consumption, and increasing efficiency. In equipment manufacturing, the company has the mass production capacity of various types of purification equipment such as ion exchange, chromatographic separation, molecular distillation, evaporation, crystallization, and drying that are independently developed. At the same time, the company's independently developed industrial automation control system integrates the overall production line process and multi-category purification technology, and creates a full-line intelligent manufacturing solution based on automation instruments and industrial software, achieving stable scale production and effective process control. Purification and separation, as the core technology for separating mixtures, purifying target substances, and removing impurities, are crucial steps in the industrial production of bio-manufacturing and other fields. Purification equipment and industrial automation control systems, as the core carriers for the scale preparation of high-purity target products, play an important role in the industrialization landing of this field. After years of development, Ousangyuan has mature process development and equipment manufacturing capabilities in subfields of bio-manufacturing such as functional sugars, starch sugars, bio-based platform compounds, and amino acids. The company can deliver complete production solutions to customers and continue to expand into other areas such as sucrose and wet metallurgy. Taking the example of the emerging synthetic bio-product allose sugar, according to Sublime China Information data, the company's market share in the allose sugar purification-related business is expected to reach 50.55% in the period from 2023 to 2025, ranking first domestically. Financially, in the years 2023, 2024, and 2025, the company achieved operating incomes of approximately 360 million yuan, 399 million yuan, and 580 million yuan respectively; during the same period, net profits were approximately 107 million yuan, 118 million yuan, and 151 million yuan respectively.